Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
28.3M
-
Shares change
-
-6.95M
-
Total reported value, excl. options
-
$182M
-
Value change
-
-$209M
-
Put/Call ratio
-
0.48
-
Number of buys
-
62
-
Number of sells
-
-73
-
Price
-
$6.44
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q1 2016
171 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q1 2016.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.3M shares
of 79.2M outstanding shares and own 35.77% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.7M shares), Sectoral Asset Management Inc (2.62M shares), VANGUARD GROUP INC (2.06M shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (1.49M shares), BlackRock Fund Advisors (1.24M shares), BB BIOTECH AG (1.18M shares), FMR LLC (1.14M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (967K shares), RENAISSANCE TECHNOLOGIES LLC (949K shares), and Camber Capital Management LLC (894K shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.